Treatment of Concurrent Minimal Change Disease and Epstein Barr Virus–Driven Post-transplant Lymphoproliferative Disorder With Rituximab Following Hematopoietic Stem Cell Transplantation

Guardat en:
Dades bibliogràfiques
Publicat a:Kidney Int Rep
Autors principals: Ainley, Louise, Law, Steven, Heptinstall, Lauren, Rodriguez-Justo, Manuel, Thomson, Kirsty, Pepper, Ruth J.
Format: Artigo
Idioma:Inglês
Publicat: Elsevier 2020
Matèries:
Nephrology Rounds
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7783564/
https://ncbi.nlm.nih.gov/pubmed/33426402
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ekir.2020.10.012
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars